APYX MEDICAL CORP (APYX)
US03837C1062 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -18.85M | -23.28M | -15.20M | -11.91M | -19.71M | |||
| Depreciation Amortization | 692.00K | 890.00K | 900.00K | 890.00K | 750.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | 0.00 | |||
| Change In Working Capital | 5.54M | -5.22M | -1.84M | -10.25M | -3.32M | |||
| Interest Paid | 1.94M | 20.00K | 10.00K | 50.00K | 10.00K | |||
| Taxes Paid | 329.00K | 130.00K | 110.00K | 80.00K | 330.00K | |||
| Other non cash items | 7.37M | 7.33M | 5.69M | 5.21M | 3.80M | |||
| OPERATING CASH FLOW | -5.25M | -20.28M | -10.45M | -16.07M | -18.48M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -533.00K | -1.01M | -720.00K | -580.00K | -1.30M | |||
| Other Investing Activity | 7.27M | N/A | N/A | 0.00 | 61.84M | |||
| INVESTING CASH FLOW | 6.73M | -1.01M | -720.00K | -580.00K | 60.54M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 29.30M | -150.00K | -240.00K | -370.00K | -60.00K | |||
| Stock Issued/Repurchased | 2.72M | 370.00K | 70.00K | 150.00K | 210.00K | |||
| Other Financing Activity | 147.00K | 0.00 | 200.00K | 150.00K | N/A | |||
| FINANCING CASH FLOW | 32.17M | 220.00K | 20.00K | -70.00K | 150.00K | |||
| Exchange Rate Effect | -191.00K | 400.00K | 100.00K | -180.00K | 0.00 | |||
| CHANGE IN CASH | 33.46M | -20.67M | -11.05M | -16.90M | 42.21M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -5.25M | -20.28M | -10.45M | -16.07M | -18.48M | |||
| Capital Expenditure | -533.00K | -1.01M | -720.00K | -580.00K | -1.30M | |||
| FREE CASH FLOW | -5.78M | -21.29M | -11.17M | -16.65M | -19.78M | |||
All data in USD